Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo
Walder, K. R., Molero, J. C., Konstantopoulos, N., Segal, D., Foletta, V., Windmill, K., Curran, J., Dyer, T., Shields, K., Jowett, J., Krippner, G., Blangero, J. and Collier, G. 2008, Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo, Diabetologia : clinical and experimental diabetes and metabolism, vol. 51, no. Supplement 1, pp. S374-S375.